Amphastar Pharma Balance Sheet - Annual (NASDAQ:AMPH)

Add to My Stocks
$16.96 $0.12 (0.71%) AMPH stock closing price Jun 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Amphastar Pharma balance sheet. Financial strength can be guaged by performing Amphastar Pharma stock analysis and by analyzing the balance sheet. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Amphastar Pharma had a long term debt of $40.84M at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Amphastar Pharma operating cash flow and Amphastar Pharma revenue also. Amphastar Pharma debt to equity ratio is 0.14.

View latest 10 year balance sheet data to check Amphastar Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Marketable Securities6.79M1.91M1.28M1.49M1.32M1.88M-
Raw Materials19.97M36.2M31.87M41.99M34.47M29.39M-
Work In Progress22.46M22.26M21.45M16.22M14.69M8.59M-
Finished Goods21.16M21.27M19.86M24.75M26.5M19.4M-
Notes Receivable-------
Other Current Assets9.75M3.27M4.43M23.21M21.12M23.93M-
Total Current Assets
Property Plant & Equipment318.66M274.95M254.41M240.84M207.19M187.11M-
Accumulated Depreciation133.32M122.01M112.25M102.55M90.57M79.75M-
Net Property Plant & Equipment
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges27.74M31M27.44M6.93M6.11M--
Deposits & Other Assets8.66M9.39M4.69M3.58M2.87M2.04M-
Total Assets
Notes Payable-------
Accounts Payable57.55M16.19M13.87M10.16M20.38M17.66M-
Current Portion Long-Term Debt6.31M5.36M10.93M7.59M22.1M22.05M-
Current Portion Capital Leases-------
Accrued Expenses-31.35M31.43M26.51M19.42M16.68M-
Income Taxes Payable3.32M7.7M3.07M4.31M2.84M3.03M-
Other Current Liabilities---14.01M---
Total Current Liabilities
Deferred Taxes/Income1.36M1.55M1.33M7.82M9.77M6.35M-
Convertible Debt-------
Long-Term Debt40.84M32.35M30.16M36.1M10.06M15.95M-
Non-Current Capital Leases-------
Other Long-Term Liabilities7.93M3.95M3.16M-1.95M1.66M-
Total Liabilities
Minority Interest-------
Preferred Stock-------
Common Stock Net-------
Capital Surplus313.89M283.12M247.82M220.74M177.73M171.48M-
Retained Earnings76.23M70.85M60.32M63.11M73.8M61.94M-
Treasury Stock50.7M20.03M10.17M----
Other Liabilities-2.1M-4.69M-2.47M-1.65M---
Shareholders Equity337.32M329.25M295.51M281.86M251.54M233.43M-
Total Liabilities & Shareholders Equity454.66M427.73M390.13M389.37M338.74M317.47M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Amphastar Pharma stock price, and Amphastar Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Amphastar Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Amphastar Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for AMPH stock as of 2017 is $454.66M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. AMPH stock had total liabilities of $117.33M for the year 2017.

Amphastar Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio